SignalFDA/Bio

Sandoz and mAbxience agree on emicizumab biosimilar partnership

Sandoz and mAbxience partner on emicizumab biosimilar, signaling biotech deal catalyst.

What changed

Sandoz and mAbxience partner on emicizumab biosimilar, signaling biotech deal catalyst.

Why it matters

Sandoz and mAbxience partner on emicizumab biosimilar, signaling biotech deal catalyst. — impact context not separately stored; see What changed.

Sources